Anavex Life Sciences Corp (AVXL)

[wildcard235]

Not for years, not after what we learned on Thursday. I put in my notes years ago to expect approval in 2022 at the earliest. I now predict an 80% chance of approval next year, and 20% chance no later than 2024.

As to what happens after that, study what has happened to pre-revenue biostocks' share prices after their first FDA approval. They go parabolic.